Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin

Authors:

Abstract
GUIDELINE TITLE: Therapeutic monitoring of vancomycin for serious methicillin‐resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health‐System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsRELEASE DATE: Online: March 19, 2020PRIOR VERSION: 2009DEVELOPERS: American Society of Health‐System Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP)FUNDING SOURCE: ASHP, IDSA, PIDS, SIDPTARGET POPULATION: Adults, children, and neonates treated for documented or presumed methicillin‐resistant Staphylococcus aureus infection
Funding Information
  • Infectious Diseases Society of America
  • Pediatric Infectious Diseases Society
  • National Institute of Allergy and Infectious Diseases (R21AI149026)

This publication has 8 references indexed in Scilit: